Instaappointment Image

RECA: Onsite Participants

Home  /  Areas of Practice  /  Radiation Exposure Compensation Act (RECA)  /  RECA: Onsite Participants

Radiation Exposure Compensation Act (RECA) Claims Assistance

  1. “Participated” in a test conducted by the United States involving the atmospheric detonation of a nuclear device (tests listed at 42 C.F.R. § 79.31(d))
  2. “Onsite”; i.e., physical presence above or within the official boundaries of any of the following test sites at any time during a period of atmospheric nuclear testing: (a) Nevada Test Site, Nevada; (b) Pacific Test Sites (Bikini Atoll, Enewetak Atoll, Johnston Island, Christmas Island, the test site for the shot during Operation Wigwam, the test site for Shot Yucca during Operation Hardtack I, and the test sites for Shot Frigate Bird and Shot Swordfish during Operation Dominic I) and the official zone around each site from which non-test affiliated ships were excluded for security and safety purposes; (c) Trinity Test Site, New Mexico; (d) South Atlantic Test Site for Operation Argus and the official zone around the site from which non-test affiliated ships were excluded for security and safety purposes; (e) Any designated location within a Naval Shipyard, Air Force Base, or other government installation where ships, aircraft, or other equipment used in an atmospheric nuclear detonation were decontaminated; or (f) Any designated location used for the purpose of monitoring fallout from an atmospheric nuclear test conducted at the Nevada Test Site; and
  3. Written medical documentation that you thereafter developed a specified compensable disease: Leukemia other than chronic lymphocytic leukemia, provided onset was at least 2 years after first exposure to fallout; or the following diseases, provided onset was at least 5 years after first exposure: Multiple Myeloma, Lymphomas (other than Hodgkin’s Disease), Primary Cancer of the Thyroid, Male or female breast, Esophagus, Stomach, Pharynx, Small intestine, Pancreas, Bile Ducts, Gall Bladder, Salivary Gland, Urinary Bladder, Brain, Colon, Ovary, Liver (provided there is no indication of the presence of hepatitis B or cirrhosis), or Lung